These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 2092110)

  • 41. Interleukin 2 soluble receptor (s-IL 2R) and lung cancer.
    Pecchio F; Rapellino M; Aimo G; Baldi S; Cunazza M; Libertucci D; Cavallo A; Oliaro A; Pagni R
    J Nucl Med Allied Sci; 1990; 34(4 Suppl):163-7. PubMed ID: 2092112
    [No Abstract]   [Full Text] [Related]  

  • 42. Serum levels of interleukin-18 (IL-18) and soluble interleukin-2 receptor (sIL-2R) in lung cancer.
    Naumnik W; Chyczewska E; Kovalchuk O; Tałałaj J; Izycki T; Panek B
    Rocz Akad Med Bialymst; 2004; 49():246-51. PubMed ID: 15631351
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The relationship between circulating concentrations of C-reactive protein, inflammatory cytokines and cytokine receptors in patients with non-small-cell lung cancer.
    McKeown DJ; Brown DJ; Kelly A; Wallace AM; McMillan DC
    Br J Cancer; 2004 Dec; 91(12):1993-5. PubMed ID: 15570310
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Soluble immunological parameters and early prognosis of renal cell cancer patients.
    Kallio JP; Tammela TL; Marttinen AT; Kellokumpu-Lehtinen PL
    J Exp Clin Cancer Res; 2001 Dec; 20(4):523-8. PubMed ID: 11876546
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Soluble interleukin-2 receptor: a new prognostic marker in lung cancer.
    Marino P; Buccheri G; Preatoni A; Ferrigno D; Cori P; Rosti A; Mozzi R; Moroni GA
    J Nucl Med Allied Sci; 1990; 34(4 Suppl):151-4. PubMed ID: 2092110
    [No Abstract]   [Full Text] [Related]  

  • 46. [The value of measuring the serum level of soluble interleukin-2 receptors in lung cancer patients].
    Siemińska A
    Pol Merkur Lekarski; 2004 Feb; 16(92):188-90. PubMed ID: 15176308
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Tumor markers in malignant lymphoma].
    Kato H; Ogura M
    Gan To Kagaku Ryoho; 2005 Jun; 32(6):883-92. PubMed ID: 15984537
    [TBL] [Abstract][Full Text] [Related]  

  • 48.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 49.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 50.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 51.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 52.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 53.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 3.